～Hidemasa's appointment bolsters Aculys' position as a leader in the field of CNS in Japan and Asia～

TOKYO, April 1, 2024 /PRNewswire/ -- Aculys Pharma, Inc. ("Aculys"), a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, today announces the appointment of Hidemasa...